1.65 USD
↗ 0.04 (2.48%)AT CLOSE (11:59 AM EDT)
Radiopharm Theranostics Limited American Depositary Shares
RADXNASDAQ • USD
1.72
↗ 0.07 (3.94%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
1.72
↗ 0.07 (3.94%)
Market: CLOSED
RADX is currently priced at $1.58. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 22, 2026.
Open?$1.69
High?$1.69
Low?$1.50
Prev. Close?$1.61
Volume?33.4K
Avg. Volume?N/A
VWAP?$1.61
Bid / Ask
Bid?$1.46 × 200
Ask?$1.72 × 100
Spread?$0.26
Midpoint?$1.59
Valuation & Ratios
Market Cap?23.5M
Shares Out?14.5M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?30.4K
Days to Cover?1.0
Avg Daily Volume83.3K
Settlement Date2026-08-31